CATHERINE MUROMBEDZI CORRESPONDENT
The evidence is finally in.
A national vaccination programme works. It works even where HIV is common.
This is the first population-level proof the world has seen. It shows that a public health system can protect the most vulnerable before the damage begins.
The study appeared in The Lancet Global Health.
Researchers from Wits RHI and the Kirby Institute led the work. They evaluated South Africa’s school-based programme. Since 2014, the government has offered free vaccines to girls in Grade 4.
These girls are nine years and older.
Most have not been exposed to the virus yet.
Winning the Fight Against High-Risk Strains
HIV changes the stakes for cervical cancer. Women living with HIV face a massive risk. They are six times more likely to develop the disease than those without the virus. The infection is persistent. High-risk strains of HPV take hold and stay.
In the past, data mostly came from women who were vaccinated after HIV infection. They were often already exposed to HPV.
Their immune systems were already suppressed.
This study was different. It looked at the real world. It looked at girls vaccinated early, through a national public health programme, in a high-burden context. The results are a landmark for global health.
Early Intervention Equals Excellent Protection
The findings are clear. The vaccine provides excellent protection. It works for girls living with HIV. It works for those without it. Researchers observed substantial reductions in vaccine-type HPV infections. High-coverage programmes deliver massive population benefits.
Professor Sinead Delany-Moretlwe, Director of Research at Wits RHI, led the study. Her message is direct. Investing in early, school-based vaccination dramatically reduces future cancer risk. It sends a clear signal to the rest of the world. Even where HIV is a heavy burden, the vaccine holds its ground and does its job.
A Global Roadmap for Saving Lives
This research matters far beyond South Africa. It provides a blueprint for countries facing the dual burden of HIV and cervical cancer. Now, there is compelling evidence to implement and sustain these programmes.
South Africa has shown that public health can reach the people who need it most. When you vaccinate early, you change the future. You stop the cancer before it begins.
This is a major victory for science and a triumph for the girls who will now grow up without the shadow of this disease. It is a major public health success that will ultimately save lives worldwide.
● Feedback: cathymwauyakufa@gmail.com
About Author
